Global VEGF Targeted Therapy Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global VEGF Targeted Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Bevacizumab
1.2.3 Ramucirumab
1.2.4 Ranibizumab
1.2.5 Aflibercept
1.2.6 Conbercept
1.2.7 Other
1.3 Market by Application
1.3.1 Global VEGF Targeted Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global VEGF Targeted Therapy Market Perspective (2021–2032)
2.2 Global VEGF Targeted Therapy Growth Trends by Region
2.2.1 Global VEGF Targeted Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 VEGF Targeted Therapy Historic Market Size by Region (2021–2026)
2.2.3 VEGF Targeted Therapy Forecasted Market Size by Region (2027–2032)
2.3 VEGF Targeted Therapy Market Dynamics
2.3.1 VEGF Targeted Therapy Industry Trends
2.3.2 VEGF Targeted Therapy Market Drivers
2.3.3 VEGF Targeted Therapy Market Challenges
2.3.4 VEGF Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top VEGF Targeted Therapy Players by Revenue
3.1.1 Global Top VEGF Targeted Therapy Players by Revenue (2021–2026)
3.1.2 Global VEGF Targeted Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top VEGF Targeted Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by VEGF Targeted Therapy Revenue
3.4 Global VEGF Targeted Therapy Market Concentration Ratio
3.4.1 Global VEGF Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by VEGF Targeted Therapy Revenue in 2025
3.5 Global Key Players of VEGF Targeted Therapy Head Offices and Areas Served
3.6 Global Key Players of VEGF Targeted Therapy, Products and Applications
3.7 Global Key Players of VEGF Targeted Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 VEGF Targeted Therapy Breakdown Data by Type
4.1 Global VEGF Targeted Therapy Historic Market Size by Type (2021–2026)
4.2 Global VEGF Targeted Therapy Forecasted Market Size by Type (2027–2032)
5 VEGF Targeted Therapy Breakdown Data by Application
5.1 Global VEGF Targeted Therapy Historic Market Size by Application (2021–2026)
5.2 Global VEGF Targeted Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America VEGF Targeted Therapy Market Size (2021–2032)
6.2 North America VEGF Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America VEGF Targeted Therapy Market Size by Country (2021–2026)
6.4 North America VEGF Targeted Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe VEGF Targeted Therapy Market Size (2021–2032)
7.2 Europe VEGF Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe VEGF Targeted Therapy Market Size by Country (2021–2026)
7.4 Europe VEGF Targeted Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific VEGF Targeted Therapy Market Size (2021–2032)
8.2 Asia-Pacific VEGF Targeted Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific VEGF Targeted Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific VEGF Targeted Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America VEGF Targeted Therapy Market Size (2021–2032)
9.2 Latin America VEGF Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America VEGF Targeted Therapy Market Size by Country (2021–2026)
9.4 Latin America VEGF Targeted Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa VEGF Targeted Therapy Market Size (2021–2032)
10.2 Middle East & Africa VEGF Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa VEGF Targeted Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa VEGF Targeted Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche VEGF Targeted Therapy Introduction
11.1.4 Roche Revenue in VEGF Targeted Therapy Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly VEGF Targeted Therapy Introduction
11.2.4 Eli Lilly Revenue in VEGF Targeted Therapy Business (2021–2026)
11.2.5 Eli Lilly Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer VEGF Targeted Therapy Introduction
11.3.4 Pfizer Revenue in VEGF Targeted Therapy Business (2021–2026)
11.3.5 Pfizer Recent Development
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals VEGF Targeted Therapy Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in VEGF Targeted Therapy Business (2021–2026)
11.4.5 Regeneron Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis VEGF Targeted Therapy Introduction
11.5.4 Novartis Revenue in VEGF Targeted Therapy Business (2021–2026)
11.5.5 Novartis Recent Development
11.6 Alphamab Oncology
11.6.1 Alphamab Oncology Company Details
11.6.2 Alphamab Oncology Business Overview
11.6.3 Alphamab Oncology VEGF Targeted Therapy Introduction
11.6.4 Alphamab Oncology Revenue in VEGF Targeted Therapy Business (2021–2026)
11.6.5 Alphamab Oncology Recent Development
11.7 Chengdu Kanghong Pharmaceutical
11.7.1 Chengdu Kanghong Pharmaceutical Company Details
11.7.2 Chengdu Kanghong Pharmaceutical Business Overview
11.7.3 Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Introduction
11.7.4 Chengdu Kanghong Pharmaceutical Revenue in VEGF Targeted Therapy Business (2021–2026)
11.7.5 Chengdu Kanghong Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global VEGF Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Bevacizumab
Table 3. Key Players of Ramucirumab
Table 4. Key Players of Ranibizumab
Table 5. Key Players of Aflibercept
Table 6. Key Players of Conbercept
Table 7. Key Players of Other
Table 8. Global VEGF Targeted Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global VEGF Targeted Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global VEGF Targeted Therapy Market Size by Region (US$ Million), 2021–2026
Table 11. Global VEGF Targeted Therapy Market Share by Region (2021–2026)
Table 12. Global VEGF Targeted Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global VEGF Targeted Therapy Market Share by Region (2027–2032)
Table 14. VEGF Targeted Therapy Market Trends
Table 15. VEGF Targeted Therapy Market Drivers
Table 16. VEGF Targeted Therapy Market Challenges
Table 17. VEGF Targeted Therapy Market Restraints
Table 18. Global VEGF Targeted Therapy Revenue by Players (US$ Million), 2021–2026
Table 19. Global VEGF Targeted Therapy Market Share by Players (2021–2026)
Table 20. Global Top VEGF Targeted Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on VEGF Targeted Therapy Revenue, 2025
Table 21. Ranking of Global Top VEGF Targeted Therapy Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by VEGF Targeted Therapy Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of VEGF Targeted Therapy, Headquarters and Area Served
Table 24. Global Key Players of VEGF Targeted Therapy, Products and Applications
Table 25. Global Key Players of VEGF Targeted Therapy, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global VEGF Targeted Therapy Market Size by Type (US$ Million), 2021–2026
Table 28. Global VEGF Targeted Therapy Revenue Market Share by Type (2021–2026)
Table 29. Global VEGF Targeted Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global VEGF Targeted Therapy Revenue Market Share by Type (2027–2032)
Table 31. Global VEGF Targeted Therapy Market Size by Application (US$ Million), 2021–2026
Table 32. Global VEGF Targeted Therapy Revenue Market Share by Application (2021–2026)
Table 33. Global VEGF Targeted Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global VEGF Targeted Therapy Revenue Market Share by Application (2027–2032)
Table 35. North America VEGF Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America VEGF Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 37. North America VEGF Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 38. Europe VEGF Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe VEGF Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 40. Europe VEGF Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific VEGF Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific VEGF Targeted Therapy Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific VEGF Targeted Therapy Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America VEGF Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America VEGF Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America VEGF Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa VEGF Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa VEGF Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa VEGF Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 50. Roche Company Details
Table 51. Roche Business Overview
Table 52. Roche VEGF Targeted Therapy Product
Table 53. Roche Revenue in VEGF Targeted Therapy Business (US$ Million), 2021–2026
Table 54. Roche Recent Development
Table 55. Eli Lilly Company Details
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly VEGF Targeted Therapy Product
Table 58. Eli Lilly Revenue in VEGF Targeted Therapy Business (US$ Million), 2021–2026
Table 59. Eli Lilly Recent Development
Table 60. Pfizer Company Details
Table 61. Pfizer Business Overview
Table 62. Pfizer VEGF Targeted Therapy Product
Table 63. Pfizer Revenue in VEGF Targeted Therapy Business (US$ Million), 2021–2026
Table 64. Pfizer Recent Development
Table 65. Regeneron Pharmaceuticals Company Details
Table 66. Regeneron Pharmaceuticals Business Overview
Table 67. Regeneron Pharmaceuticals VEGF Targeted Therapy Product
Table 68. Regeneron Pharmaceuticals Revenue in VEGF Targeted Therapy Business (US$ Million), 2021–2026
Table 69. Regeneron Pharmaceuticals Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis VEGF Targeted Therapy Product
Table 73. Novartis Revenue in VEGF Targeted Therapy Business (US$ Million), 2021–2026
Table 74. Novartis Recent Development
Table 75. Alphamab Oncology Company Details
Table 76. Alphamab Oncology Business Overview
Table 77. Alphamab Oncology VEGF Targeted Therapy Product
Table 78. Alphamab Oncology Revenue in VEGF Targeted Therapy Business (US$ Million), 2021–2026
Table 79. Alphamab Oncology Recent Development
Table 80. Chengdu Kanghong Pharmaceutical Company Details
Table 81. Chengdu Kanghong Pharmaceutical Business Overview
Table 82. Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Product
Table 83. Chengdu Kanghong Pharmaceutical Revenue in VEGF Targeted Therapy Business (US$ Million), 2021–2026
Table 84. Chengdu Kanghong Pharmaceutical Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Authors List of This Report


List of Figures
Figure 1. VEGF Targeted Therapy Picture
Figure 2. Global VEGF Targeted Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global VEGF Targeted Therapy Market Share by Type: 2025 vs 2032
Figure 4. Bevacizumab Features
Figure 5. Ramucirumab Features
Figure 6. Ranibizumab Features
Figure 7. Aflibercept Features
Figure 8. Conbercept Features
Figure 9. Other Features
Figure 10. Global VEGF Targeted Therapy Market Size by Application (US$ Million), 2021–2032
Figure 11. Global VEGF Targeted Therapy Market Share by Application: 2025 vs 2032
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. VEGF Targeted Therapy Report Years Considered
Figure 15. Global VEGF Targeted Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global VEGF Targeted Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global VEGF Targeted Therapy Market Share by Region: 2025 vs 2032
Figure 18. Global VEGF Targeted Therapy Market Share by Players in 2025
Figure 19. Global VEGF Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by VEGF Targeted Therapy Revenue in 2025
Figure 21. North America VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America VEGF Targeted Therapy Market Share by Country (2021–2032)
Figure 23. United States VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe VEGF Targeted Therapy Market Share by Country (2021–2032)
Figure 27. Germany VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific VEGF Targeted Therapy Market Share by Region (2021–2032)
Figure 35. China VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America VEGF Targeted Therapy Market Share by Country (2021–2032)
Figure 43. Mexico VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa VEGF Targeted Therapy Market Share by Country (2021–2032)
Figure 47. Israel VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE VEGF Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Roche Revenue Growth Rate in VEGF Targeted Therapy Business (2021–2026)
Figure 51. Eli Lilly Revenue Growth Rate in VEGF Targeted Therapy Business (2021–2026)
Figure 52. Pfizer Revenue Growth Rate in VEGF Targeted Therapy Business (2021–2026)
Figure 53. Regeneron Pharmaceuticals Revenue Growth Rate in VEGF Targeted Therapy Business (2021–2026)
Figure 54. Novartis Revenue Growth Rate in VEGF Targeted Therapy Business (2021–2026)
Figure 55. Alphamab Oncology Revenue Growth Rate in VEGF Targeted Therapy Business (2021–2026)
Figure 56. Chengdu Kanghong Pharmaceutical Revenue Growth Rate in VEGF Targeted Therapy Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit